Em. Obrien et al., INTERACTIONS OF SOME ANALOGS OF THE ANTICONVULSANT MILACEMIDE WITH MONOAMINE-OXIDASE, Biochemical pharmacology, 48(5), 1994, pp. 905-914
A series of analogues of the anticonvulsant drug milacemide (2-(n-pent
ylamino)-acetamide; Compound I) has been synthesizes: 2-(benzylamino)a
cetamide (Compound II), 2-(phenethylamino)acetamide (Compound III), 2-
(2-indol-3-yl)-ethylamino acetamide (Compound IV), 2-(2-(5-methoxyindo
l-3-yl)ethylamino)-acetamide (Compound V), 2-(2(4-chlorobenzamido)-eth
ylamino)acetamide (Compound VI), 2-(2-benzamidoethylamino)-acetamide (
Compound VII) and 2-(4-(3-chlorobenzyloxy)phenthylamino)acetamide (Com
pound VIII). These compounds involve retention of the aminoacetamide p
ortion of milacemide but replacement of the pentyl moiety with aromati
c residues present in the structures of substrates and inhibitors of t
he monoamine oxidases. All the compounds tested were substrates for ox
liver monoamine oxidase-B (MAO-B), producing an aldehyde that could a
ct as a substrate for ox liver aldehyde dehydrogenase and H2O2 as a re
sult of oxidative cleavage which also released glycinamide, although t
heir Michaelis-Menten parameters differed markedly. None showed detect
able activity as substrates for rat liver monoamine oxidase-A (MAO-A).
Inhibition of the MAO-B by all the compounds except Compounds VIII an
d IV showed marked time dependence and was at least partly irreversibl
e. There was no apparent change in the inhibition of MAO-A during enzy
me-inhibitor preincubation at 37 degrees for 60 min. Compound VIII was
a potent reversible inhibitor of both MAO-A and MAO-B (K-i = 2.8 +/-
0.1 and 4.1 +/- 0.8 mu M), respectively. Comparison of the inhibitory
potencies and the specificity constants of the series of compounds as
substrates for MAO-B revealed no simple correlations with thier antico
nvulsant activities, as measured by their ability to prevent bicuculli
ne-induced convlusions and death in the mouse. These results suggest t
hat neither inhibition of MAO nor oxidative cleavage by this enzyme to
yield glycinamide plays the major role in the anticonvulsant action o
f these compounds.